Tang Mitosis/Apoptosis ver. II - Dataset (ID:20003)
Download: Excel (XLSX), Comma-separated (CSV)
Small Molecule | Cell Line | Assay compound conc (uM) | Day | Image | Cell count | Interphase count | Apoptotic count | Dead count | Mitotic count | % Interphase | % Apoptotic | % Mitotic | Recorded Plate | Recorded Well | Control Type |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Calu-3 | 2 | 272 | 157 | 89 | 1 | 25 | 57.72 | 33.09 | 9.19 | 6 | E11 | N | |||
Calu-3 | 3 | 276 | 145 | 80 | 8 | 43 | 52.54 | 31.88 | 15.58 | 6 | E11 | N | |||
MLN8054 | Calu-3 | 0.0051 | 1 | 185 | 76 | 72 | 2 | 35 | 41.08 | 40.00 | 18.92 | 6 | E12 | ||
MLN8054 | Calu-3 | 0.0051 | 2 | 234 | 88 | 101 | 8 | 37 | 37.61 | 46.58 | 15.81 | 6 | E12 | ||
MLN8054 | Calu-3 | 0.0051 | 3 | 296 | 185 | 77 | 5 | 29 | 62.50 | 27.70 | 9.80 | 6 | E12 | ||
Tozasertib | Calu-3 | 3.7 | 1 | 244 | 118 | 57 | 4 | 65 | 48.36 | 25.00 | 26.64 | 6 | E13 | ||
Tozasertib | Calu-3 | 3.7 | 2 | 235 | 110 | 59 | 14 | 52 | 46.81 | 31.06 | 22.13 | 6 | E13 | ||
Tozasertib | Calu-3 | 3.7 | 3 | 214 | 137 | 48 | 6 | 23 | 64.02 | 25.23 | 10.75 | 6 | E13 | ||
Calu-3 | 1 | 189 | 84 | 62 | 3 | 40 | 44.44 | 34.39 | 21.16 | 6 | E14 | N | |||
Calu-3 | 2 | 284 | 116 | 129 | 7 | 32 | 40.85 | 47.89 | 11.27 | 6 | E14 | N | |||
Calu-3 | 3 | 261 | 155 | 71 | 6 | 29 | 59.39 | 29.50 | 11.11 | 6 | E14 | N | |||
Tozasertib | Calu-3 | 3.7 | 1 | 215 | 127 | 57 | 5 | 26 | 59.07 | 28.84 | 12.09 | 6 | E15 | ||
Tozasertib | Calu-3 | 3.7 | 2 | 207 | 103 | 67 | 3 | 34 | 49.76 | 33.82 | 16.43 | 6 | E15 | ||
Tozasertib | Calu-3 | 3.7 | 3 | 188 | 123 | 40 | 4 | 21 | 65.43 | 23.40 | 11.17 | 6 | E15 | ||
GSK1070916 | Calu-3 | 3.7 | 1 | 181 | 37 | 94 | 5 | 45 | 20.44 | 54.70 | 24.86 | 6 | E16 | ||
GSK1070916 | Calu-3 | 3.7 | 2 | 221 | 74 | 114 | 6 | 27 | 33.48 | 54.30 | 12.22 | 6 | E16 | ||
GSK1070916 | Calu-3 | 3.7 | 3 | 213 | 117 | 83 | 7 | 6 | 54.93 | 42.25 | 2.82 | 6 | E16 | ||
Tozasertib | Calu-3 | 0.0051 | 1 | 247 | 116 | 84 | 3 | 44 | 46.96 | 35.22 | 17.81 | 6 | E17 | ||
Tozasertib | Calu-3 | 0.0051 | 2 | 228 | 98 | 88 | 8 | 34 | 42.98 | 42.11 | 14.91 | 6 | E17 | ||
Tozasertib | Calu-3 | 0.0051 | 3 | 222 | 115 | 70 | 8 | 29 | 51.80 | 35.14 | 13.06 | 6 | E17 | ||
GSK1070916 | Calu-3 | 3.7 | 1 | 198 | 48 | 100 | 4 | 46 | 24.24 | 52.53 | 23.23 | 6 | E18 | ||
GSK1070916 | Calu-3 | 3.7 | 2 | 204 | 86 | 98 | 4 | 16 | 42.16 | 50.00 | 7.84 | 6 | E18 | ||
GSK1070916 | Calu-3 | 3.7 | 3 | 204 | 98 | 83 | 5 | 18 | 48.04 | 43.14 | 8.82 | 6 | E18 | ||
Tozasertib | Calu-3 | 0.0051 | 1 | 173 | 72 | 59 | 4 | 38 | 41.62 | 36.42 | 21.97 | 6 | E19 | ||
Tozasertib | Calu-3 | 0.0051 | 2 | 214 | 96 | 88 | 3 | 27 | 44.86 | 42.52 | 12.62 | 6 | E19 |